The initial public offering (IPO) of Supriya Lifesciences was subscribed 74x on Monday, the concluding day of its issue. The institutional portion was subscribed 33x, the wealthy investor portion 166x, and the retail investor portion 57x.
Supriya Lifesciences had priced its IPO between Rs 265 and Rs 274 per share. The Rs 700-crore IPO comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 500 crore.
The company’s promoter Satish Waman Bagh divested shares worth Rs 500 crore through the IPO. ICICI Securities and Axis Capital were the book-running lead managers.

)